美年健康
(002044)
| 流通市值：202.92亿 | | | 总市值：205.11亿 |
| 流通股本：38.72亿 | | | 总股本：39.14亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,754,077,010.26 | 10,701,990,901.1 | 7,140,540,911.69 | 4,205,187,220.8 |
| 营业收入 | 1,754,077,010.26 | 10,701,990,901.1 | 7,140,540,911.69 | 4,205,187,220.8 |
| 二、营业总成本 | 2,098,784,567.24 | 9,931,165,146 | 6,938,686,419.55 | 4,379,292,978.14 |
| 营业成本 | 1,332,388,282 | 6,123,339,473.89 | 4,307,721,776.06 | 2,705,906,975.07 |
| 税金及附加 | 1,577,678.94 | 7,667,178.16 | 3,229,747.69 | 2,280,332.93 |
| 销售费用 | 469,847,155.22 | 2,545,754,935.87 | 1,717,818,887.17 | 1,076,066,714.49 |
| 管理费用 | 208,131,402.48 | 884,622,864.45 | 638,778,802.48 | 416,832,558.53 |
| 研发费用 | 12,972,250.4 | 54,961,812.76 | 37,492,770.55 | 25,544,147.29 |
| 财务费用 | 73,867,798.2 | 314,818,880.87 | 233,644,435.6 | 152,662,249.83 |
| 其中:利息费用 | 76,356,784.7 | 319,374,299.01 | 238,382,107.66 | 157,648,141.85 |
| 其中:利息收入 | 4,062,380.17 | 12,665,539.29 | 10,118,380.08 | 8,105,633.52 |
| 加:公允价值变动收益 | -50,297.45 | 4,410,783.15 | 1,433,500.9 | -6,287,006.83 |
| 加:投资收益 | -3,367,598.1 | 12,448,889.37 | -9,295,368.52 | -15,752,597.45 |
| 资产处置收益 | -2,753,410.11 | -8,491,372.66 | -6,773,287.36 | -2,958,523.17 |
| 资产减值损失(新) | - | -40,484,812.95 | -564,887.75 | -322,793 |
| 信用减值损失(新) | 9,984,502.75 | -148,036,901.89 | -101,816,853.71 | -47,778,439.23 |
| 其他收益 | 4,808,652.97 | 21,918,171.76 | 14,416,271.98 | 7,964,493.18 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -336,085,706.92 | 612,590,511.88 | 99,253,867.68 | -239,240,623.84 |
| 加:营业外收入 | 1,513,878.78 | 7,961,387.13 | 4,326,096.29 | 3,570,238.37 |
| 减:营业外支出 | 6,381,031.55 | 28,034,259.97 | 14,674,122.62 | 11,855,817.54 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -340,952,859.69 | 592,517,639.04 | 88,905,841.35 | -247,526,203.01 |
| 减:所得税费用 | -43,334,975.51 | 183,527,817.56 | 8,364,214.61 | -38,441,461.61 |
| 六、净利润 | -297,617,884.18 | 408,989,821.48 | 80,541,626.74 | -209,084,741.4 |
| 持续经营净利润 | -297,617,884.18 | 408,989,821.48 | 80,541,626.74 | -209,084,741.4 |
| 归属于母公司股东的净利润 | -275,338,119.16 | 282,237,728.37 | 24,632,532.07 | -215,777,193.4 |
| 少数股东损益 | -22,279,765.02 | 126,752,093.11 | 55,909,094.67 | 6,692,452 |
| (一)基本每股收益 | -0.07 | 0.07 | 0.01 | -0.06 |
| (二)稀释每股收益 | -0.07 | 0.07 | 0.01 | -0.06 |
| 八、其他综合收益 | -16,587.45 | 202,657.93 | -117,911.1 | 750,889.73 |
| 归属于母公司股东的其他综合收益 | 4,639.57 | 58,659.65 | -70,090.62 | 701,029.75 |
| 九、综合收益总额 | -297,634,471.63 | 409,192,479.41 | 80,423,715.64 | -208,333,851.67 |
| 归属于母公司股东的综合收益总额 | -275,333,479.59 | 282,296,388.02 | 24,562,441.45 | -215,076,163.65 |
| 归属于少数股东的综合收益总额 | -22,300,992.04 | 126,896,091.39 | 55,861,274.19 | 6,742,311.98 |
| 公告日期 | 2025-04-30 | 2025-04-17 | 2024-10-31 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |